AN UNDETECTABLE PB MRD STATUS SHOULD BE THE THERAPEUTIC GOAL WITH VENETOCLAX THERAPY IN RELAPSED/ REFRACTORY CLL. (12th June 2019) - Handunnetti, S.M.; Lew, T.E.; Lin, V.S.; Anderson, M.A.; Carney, D.; Wolf, M.; Came, N.; Juneja, S.; Westerman, D.; Tam, C.S.; Roberts, A.W.; Seymour, J.F.